Details of the Drug Formulation (DFM)
General Information of DFM (ID: F24243) | |||||
---|---|---|---|---|---|
Name |
Etoposide Phosphate eq 100mg base/vial injectable
|
||||
Company |
E.R. Squibb & Sons L.L.C.; H2-Pharma
|
||||
Active Pharmaceutical Ingredient (API) | Etoposide | API Info click to show the detail info of this API | |||
Testicular carcinoma | ICD-11: 2C80 | Approved | |||
Drug Inactive Ingredient (DIGs) | |||||
DIG ID | DIG Info | DIG Name | DIG Functional Class | ||
E0D2FK | DIG Info | Dextran | Lyophilization aid | ||
E0M5SQ | DIG Info | Sodium citrate anhydrous | Alkalizing agent ... | ||
Full List of Biological Targets of DIG (DBTs) Regulated by DIG(s) in This DFM | ||||||
---|---|---|---|---|---|---|
Lyase/isomerase/ligase (L/I/G) | ||||||
DBT Name: Carbonic anhydrase IV (CA4) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Interacting DIG | Sodium citrate anhydrous | |||||
Biological Activity | Ki = 99 nM (tested by experiment) | [1] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | CAH4_HUMAN | |||||
References | |||||
---|---|---|---|---|---|
1 | Carbonic anhydrase inhibitors. Interaction of isozymes I, II, IV, V, and IX with carboxylates. Bioorg Med Chem Lett. 2005 Feb 1; 15(3):573-8. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.